Award

PICCOS TRIAL

NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST)

This public procurement record has 1 release in its history.

Summary of the contracting process

The NHS Wales Shared Services Partnership-Procurement Services, located in Cardiff, UK, initiated a tender process for the procurement of services related to the successful completion of the "PICCOS TRIAL". This trial, awarded without prior competition, aims to explore new chemotherapy delivery methods for patients with peritoneal metastases. The Cardiff University has been selected as the supplier due to its expertise in this research area. The procurement process was completed on May 11, 2023, and the contract value is £1,974,920.41.

This procurement opportunity within the healthcare industry presents business growth potential for service providers specializing in oncology research and medical technology. Companies with experience in drug delivery systems and cancer treatment innovation would be well-suited to compete in similar future tenders. By monitoring similar award procedures, businesses can identify emerging research opportunities and collaborations within the healthcare sector, particularly in the development of novel treatment approaches like Pressurised IntraPeritoneal Aerosol Chemotherapy (PIPAC).

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

PICCOS TRIAL

Notice Description

This trial aims to determine if a new way of delivering chemotherapy as a spray, directly into the peritoneal cavity, might improve survival in patients with peritoneal metastases, compared to conventional intravenous chemotherapy.

Lot Information

Lot 1

Bowel, ovarian and stomach cancer often spreads to the lining of the abdominal cavity. This trial aims to determine if a new way of delivering chemotherapy as a spray, directly into the peritoneal cavity, might improve survival in patients with peritoneal metastases, compared to conventional intravenous chemotherapy. Critically, we will also assess the impact of treatment on patient quality of life. Up to 13%, 50% and 14% of patients with bowel, ovarian and stomach cancer respectively, present with peritoneal metastases. When this form of spread occurs, patients are normally told their disease is incurable. As well as a relatively rapid decline, peritoneal metastases can cause a series of unpleasant symptoms due to new tumour growth. Peritoneal metastases are difficult to treat with conventional anticancer drugs and there is an urgent need to develop new treatment strategies. A new strategy showing potential is Pressurised IntraPeritoneal Aerosol Chemotherapy (PIPAC). PIPAC delivers anti-cancer drugs into the peritoneal cavity as an aerosol during keyhole surgery. PIPAC has been shown to deliver higher doses of chemotherapy directly to tumour sites compared to conventional treatment, with fewer side-effects due to less chemotherapy circulating in the blood. PIPAC has been shown to be both safe and feasible in a series of clinical trials. The question that now remains is whether PIPAC is efficacious or not. PIPAC has excited much interest in patient groups. CAV will disseminate study results through social media, relevant charitable organisations, presentation at academic conferences, peer-reviewed journals as well as through the trial web page hosted at the Centre for Trials Research. Information leaflets, public presentations and media coverage are integral elements of our public engagement plans. The results will strongly influence a future NICE review of PIPAC in the UK.

Procurement Information

This contract will be awarded to the Cardiff University, who have senior personnel with a large amount of experience in this area of research who are leading on this research project.

Publication & Lifecycle

Open Contracting ID
ocds-kuma6s-131480
Publication Source
Sell2Wales
Latest Notice
https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=131480
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
OJEU - F15 - Voluntary Ex Ante Transparency Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Limited
Procurement Method Details
Award procedure without prior publication of a call for competition
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

79 - Business services: law, marketing, consulting, recruitment, printing and security


CPV Codes

79314000 - Feasibility study

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£1,974,920 £1M-£10M

Notice Dates

Publication Date
11 May 20232 years ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
11 May 20232 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Not Specified
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST)
Contact Name
Rob Hollands
Contact Email
robert.d.hollands@wales.nhs.uk
Contact Phone
Not specified

Buyer Location

Locality
CARDIFF
Postcode
CF15 7QZ
Post Town
Cardiff
Country
Wales

Major Region (ITL 1)
TLL Wales
Basic Region (ITL 2)
TLL5 South East Wales
Small Region (ITL 3)
TLL51 Central Valleys and Bridgend
Delivery Location
TLL22 Cardiff and Vale of Glamorgan

Local Authority
Rhondda Cynon Taf
Electoral Ward
Taff's Well
Westminster Constituency
Cardiff North

Supplier Information

Number of Suppliers
1
Supplier Name

CARDIFF UNIVERSITY

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-kuma6s-131480-2023-05-11T00:00:00Z",
    "date": "2023-05-11T00:00:00Z",
    "ocid": "ocds-kuma6s-131480",
    "initiationType": "tender",
    "parties": [
        {
            "id": "org-4",
            "name": "NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)",
            "identifier": {
                "legalName": "NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)"
            },
            "address": {
                "streetAddress": "4-5 Charnwood Court,, Heol Billingsley, Parc Nantgarw",
                "locality": "Cardiff",
                "region": "UK",
                "postalCode": "CF15 7QZ"
            },
            "contactPoint": {
                "name": "Rob Hollands",
                "email": "robert.d.hollands@wales.nhs.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Body governed by public law",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "07",
                        "description": "Health",
                        "scheme": "COFOG"
                    }
                ],
                "url": "http://nwssp.nhs.wales/ourservices/procurement-services/"
            }
        },
        {
            "id": "org-11",
            "name": "CARDIFF UNIVERSITY",
            "identifier": {
                "legalName": "CARDIFF UNIVERSITY"
            },
            "address": {
                "streetAddress": "CARDIFF UNIVERSITY, 30 36 NEWPORT ROAD",
                "locality": "CARDIFF",
                "region": "UK",
                "postalCode": "CF240DE"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "org-6",
            "name": "High Court",
            "identifier": {
                "legalName": "High Court"
            },
            "address": {
                "streetAddress": "Royal Courts of Justice, The Strand",
                "locality": "London",
                "postalCode": "WC2A 2LL"
            },
            "contactPoint": {
                "telephone": "+44 2079477501"
            },
            "roles": [
                "reviewBody"
            ]
        }
    ],
    "buyer": {
        "name": "NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)",
        "id": "org-4"
    },
    "tender": {
        "id": "ocds-kuma6s-131480-tender-131480-CAV-STA (22-23) 212",
        "title": "PICCOS TRIAL",
        "description": "This trial aims to determine if a new way of delivering chemotherapy as a spray, directly into the peritoneal cavity, might improve survival in patients with peritoneal metastases, compared to conventional intravenous chemotherapy.",
        "status": "complete",
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "id": "79314000",
                        "scheme": "CPV"
                    }
                ],
                "deliveryLocation": {
                    "description": "University Hospital of Wales."
                },
                "deliveryAddresses": [
                    {
                        "region": "UKL22"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "procurementMethod": "limited",
        "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
        "procurementMethodRationale": "This contract will be awarded to the Cardiff University, who have senior personnel with a large amount of experience in this area of research who are leading on this research project.",
        "mainProcurementCategory": "services",
        "documents": [
            {
                "id": "MAY437035",
                "documentType": "awardNotice",
                "title": "PICCOS TRIAL",
                "description": "This trial aims to determine if a new way of delivering chemotherapy as a spray, directly into the peritoneal cavity, might improve survival in patients with peritoneal metastases, compared to conventional intravenous chemotherapy.",
                "url": "https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=MAY437035",
                "format": "text/html"
            }
        ],
        "lots": [
            {
                "id": "1",
                "description": "Bowel, ovarian and stomach cancer often spreads to the lining of the abdominal cavity. This trial aims to determine if a new way of delivering chemotherapy as a spray, directly into the peritoneal cavity, might improve survival in patients with peritoneal metastases, compared to conventional intravenous chemotherapy. Critically, we will also assess the impact of treatment on patient quality of life. Up to 13%, 50% and 14% of patients with bowel, ovarian and stomach cancer respectively, present with peritoneal metastases. When this form of spread occurs, patients are normally told their disease is incurable. As well as a relatively rapid decline, peritoneal metastases can cause a series of unpleasant symptoms due to new tumour growth. Peritoneal metastases are difficult to treat with conventional anticancer drugs and there is an urgent need to develop new treatment strategies. A new strategy showing potential is Pressurised IntraPeritoneal Aerosol Chemotherapy (PIPAC). PIPAC delivers anti-cancer drugs into the peritoneal cavity as an aerosol during keyhole surgery. PIPAC has been shown to deliver higher doses of chemotherapy directly to tumour sites compared to conventional treatment, with fewer side-effects due to less chemotherapy circulating in the blood. PIPAC has been shown to be both safe and feasible in a series of clinical trials. The question that now remains is whether PIPAC is efficacious or not. PIPAC has excited much interest in patient groups. CAV will disseminate study results through social media, relevant charitable organisations, presentation at academic conferences, peer-reviewed journals as well as through the trial web page hosted at the Centre for Trials Research. Information leaflets, public presentations and media coverage are integral elements of our public engagement plans. The results will strongly influence a future NICE review of PIPAC in the UK.",
                "status": "complete",
                "hasOptions": false
            }
        ],
        "coveredBy": [
            "GPA"
        ],
        "procurementMethodRationaleClassifications": [
            {
                "id": "D_OUTSIDE_SCOPE",
                "description": "The procurement falls outside the scope of application of the directive"
            }
        ],
        "classification": {
            "id": "79314000",
            "scheme": "CPV"
        },
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        }
    },
    "awards": [
        {
            "id": "ocds-kuma6s-131480-award-131480-5",
            "suppliers": [
                {
                    "id": "org-11",
                    "name": "CARDIFF UNIVERSITY"
                }
            ],
            "relatedLots": [
                "1"
            ]
        }
    ],
    "contracts": [
        {
            "id": "ocds-kuma6s-131480-award-131480-5",
            "awardID": "ocds-kuma6s-131480-award-131480-5",
            "status": "active",
            "value": {
                "amount": 1974920.41,
                "currency": "GBP"
            },
            "dateSigned": "2023-05-11T00:00:00Z"
        }
    ],
    "language": "EN",
    "description": "This VEAT will be in place for 10 calendar days from 11th May 2023 until 22nd May 2023. NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at http://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=131480. (WA Ref:131480)",
    "links": [
        {
            "rel": "canonical",
            "href": "https://api.sell2wales.gov.wales/v1?lang=cy/Notice?id=ocds-kuma6s-131480"
        }
    ],
    "noticetype": "OJEU - F15 - Voluntary Ex Ante Transparency Notice"
}